Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Cronin, Mark Timothy David
Galli, Corrado Lodovico
Hollnagel, Heli Miriam
MetadataShow full item record
TitleOrigin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.
Published inCrit Rev Toxicol 2017; 47(8):705-27
PubliekssamenvattingThe threshold of toxicological concern (TTC) approach is a resource-effective de minimis method for the safety assessment of chemicals, based on distributional analysis of the results of a large number of toxicological studies. It is being increasingly used to screen and prioritize substances with low exposure for which there is little or no toxicological information. The first step in the approach is the identification of substances that may be DNA-reactive mutagens, to which the lowest TTC value is applied. This TTC value was based on the analysis of the cancer potency database and involved a number of assumptions that no longer reflect the state-of-the-science and some of which were not as transparent as they could have been. Hence, review and updating of the database is proposed, using inclusion and exclusion criteria reflecting current knowledge. A strategy for the selection of appropriate substances for TTC determination, based on consideration of weight of evidence for genotoxicity and carcinogenicity is outlined. Identification of substances that are carcinogenic by a DNA-reactive mutagenic mode of action and those that clearly act by a non-genotoxic mode of action will enable the protectiveness to be determined of both the TTC for DNA-reactive mutagenicity and that applied by default to substances that may be carcinogenic but are unlikely to be DNA-reactive mutagens (i.e. for Cramer class I-III compounds). Critical to the application of the TTC approach to substances that are likely to be DNA-reactive mutagens is the reliability of the software tools used to identify such compounds. Current methods for this task are reviewed and recommendations made for their application.
- Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet.
- Authors: Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos JG, Würtzen G, European branch of the International Life Sciences Institute.
- Issue date: 2004 Jan
- Mutagenic impurities in pharmaceuticals: a critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits.
- Authors: Snodin DJ, McCrossen SD
- Issue date: 2013 Nov
- Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
- Authors: Galloway SM, Vijayaraj Reddy M, McGettigan K, Gealy R, Bercu J
- Issue date: 2013 Aug
- In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances.
- Authors: Bercu JP, Morton SM, Deahl JT, Gombar VK, Callis CM, van Lier RB
- Issue date: 2010 Jul-Aug